YWHAH expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.509600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.087400E-01
Normal-vs-Stage2
9.085400E-01
Normal-vs-Stage3
9.268600E-01
Normal-vs-Stage4
4.464600E-01
Stage1-vs-Stage2
5.738000E-01
Stage1-vs-Stage3
8.090000E-01
Stage1-vs-Stage4
2.926600E-01
Stage2-vs-Stage3
9.171600E-01
Stage2-vs-Stage4
3.393200E-01
Stage3-vs-Stage4
3.435200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.061000E-01
Normal-vs-AfricanAmerican
9.787800E-01
Normal-vs-Asian
9.714200E-01
Caucasian-vs-AfricanAmerican
8.239000E-01
Caucasian-vs-Asian
7.508600E-01
AfricanAmerican-vs-Asian
9.889400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.034600E-01
Normal-vs-Female
9.122600E-01
Male-vs-Female
1.647970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.423600E-01
Normal-vs-Age(41-60Yrs)
9.585400E-01
Normal-vs-Age(61-80Yrs)
9.141600E-01
Normal-vs-Age(81-100Yrs)
8.118200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.214400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.891200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.877200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.050800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.129400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.081000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.923400E-01
Normal-vs-Daily Drinker
4.652400E-01
Normal-vs-Weekly Drinker
9.176400E-01
Normal-vs-Occasional Drinker
7.877800E-01
Normal-vs-Social Drinker
8.058800E-01
Non Drinker-vs-Daily Drinker
1.716580E-01
Non Drinker-vs-Weekly Drinker
8.393600E-01
Non Drinker-vs-Occasional Drinker
5.085000E-01
Non Drinker-vs-Social Drinker
6.821600E-01
Daily Drinker-vs-Weekly Drinker
1.007790E-01
Daily Drinker-vs-Occasional Drinker
9.900400E-02
Daily Drinker-vs-Social Drinker
3.338000E-01
Weekly Drinker-vs-Occasional Drinker
6.548200E-01
Weekly Drinker-vs-Social Drinker
4.959800E-01
Occasional Drinker-vs-Social Drinker
3.330400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.743400E-01
Normal-vs-Grade 2
2.114800E-01
Normal-vs-Grade 3
3.446400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.967700E-02
Grade 1-vs-Grade 3
5.701800E-01
Grade 1-vs-Grade 4
4.743400E-01
Grade 2-vs-Grade 3
1.730410E-01
Grade 2-vs-Grade 4
2.114800E-01
Grade 3-vs-Grade 4
3.446400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.027200E-01
Normal-vs-NonDiabetic
9.386000E-01
Diabetic-vs-NonDiabetic
8.069000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.426400E-01
Normal-vs-NoPancreatitis
9.155400E-01
Pancreatitis-vs-NoPancreatitis
7.202200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.404200E-01
Normal-vs-N1
9.824400E-01
N0-vs-N1
5.336200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.221800E-01
Normal-vs-TP53-NonMutant
6.656200E-01
TP53-Mutant-vs-TP53-NonMutant
7.738800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
